F Akritidou1, A Praidou2, T Papamitsou3, V Kozobolis4, G Labiris4. 1. Department of Ophthalmology, General Hospital of Serres, Greece. 2. Department of Ophthalmology, General Hospital of Thessaloniki "G.Gennimatas-O Agios Dimitrios", Thessaloniki, Greece. 3. Department of Histology-Embryology, Aristotle University of Thessaloniki, Greece. 4. Department of Ophthalmology, Democritus University of Thrace, Alexandroupolis, Greece.
Abstract
BACKGROUND: Ocular involvement in patients with transfusion-dependent β-thalassemia is quite common, and its frequency differs among studies. This case series aimed to describe the ocular abnormalities occurring in β-thalassemia patients who need regular blood transfusions and receive iron chelation therapy. CASE SERIES: This is a case series prospectively studied 32 β-thalassemia patients from Northern Greece receiving regular blood transfusions and iron-chelating therapy. Patients' average age was 35.5 years. Eighteen patients with major phenotypes and fourteen patients with intermedia type underwent comprehensive ophthalmic examination at the time of enrolment, including visual acuity evaluation, refraction and color vision tests, Amsler grid test, slit-lamp, and dilated-pupil fundus examination. Additionally, we performed visual field testing and optical coherence tomography in all patients and fluorescein angiography only in selected cases. After six months, patients' complete ophthalmic examination was repeated for any new ocular findings due to the disease process and iron chelation therapy. Ocular involvement was detected in 46.87 % of the patients. Lesions were most frequently seen in elderly patients with thalassemia major. Lens opacities were present in 21.8 %, and degeneration of the retinal pigment epithelium was described in 15.6 % of the patients, representing the commonest fundus alteration observed, followed by fundus atrophy. The most severe and vision-threatening condition described in this study was the presence of angioid streaks with choroidal neovascularisation. Six months follow-up of patients did not reveal any new ocular findings. CONCLUSION: Early detection of severe ocular abnormalities is important in patients with thalassemia; thus, an ophthalmologic examination should be included at regular check-ups. An annual examination is currently indicated for asymptomatic patients, while in symptomatic and complicated cases, patients should be closely followed-up. HIPPOKRATIA 2021, 25 (2):79-82. Copyright 2021, Hippokratio General Hospital of Thessaloniki.
BACKGROUND: Ocular involvement in patients with transfusion-dependent β-thalassemia is quite common, and its frequency differs among studies. This case series aimed to describe the ocular abnormalities occurring in β-thalassemia patients who need regular blood transfusions and receive iron chelation therapy. CASE SERIES: This is a case series prospectively studied 32 β-thalassemia patients from Northern Greece receiving regular blood transfusions and iron-chelating therapy. Patients' average age was 35.5 years. Eighteen patients with major phenotypes and fourteen patients with intermedia type underwent comprehensive ophthalmic examination at the time of enrolment, including visual acuity evaluation, refraction and color vision tests, Amsler grid test, slit-lamp, and dilated-pupil fundus examination. Additionally, we performed visual field testing and optical coherence tomography in all patients and fluorescein angiography only in selected cases. After six months, patients' complete ophthalmic examination was repeated for any new ocular findings due to the disease process and iron chelation therapy. Ocular involvement was detected in 46.87 % of the patients. Lesions were most frequently seen in elderly patients with thalassemia major. Lens opacities were present in 21.8 %, and degeneration of the retinal pigment epithelium was described in 15.6 % of the patients, representing the commonest fundus alteration observed, followed by fundus atrophy. The most severe and vision-threatening condition described in this study was the presence of angioid streaks with choroidal neovascularisation. Six months follow-up of patients did not reveal any new ocular findings. CONCLUSION: Early detection of severe ocular abnormalities is important in patients with thalassemia; thus, an ophthalmologic examination should be included at regular check-ups. An annual examination is currently indicated for asymptomatic patients, while in symptomatic and complicated cases, patients should be closely followed-up. HIPPOKRATIA 2021, 25 (2):79-82. Copyright 2021, Hippokratio General Hospital of Thessaloniki.
Authors: Giulio Barteselli; Laura Dell'arti; Robert P Finger; Peter Charbel Issa; Alessia Marcon; Diego Vezzola; Chiara Mapelli; Elena Cassinerio; Maria D Cappellini; Roberto Ratiglia; Francesco Viola Journal: Ophthalmology Date: 2013-12-04 Impact factor: 12.079
Authors: S P Gartaganis; C D Georgakopoulos; A Exarchou; E K Mela; C Psachoulia; M I Eliopoulou; A Kourakli; S S Gotsis; R C Tripathi Journal: Cornea Date: 2003-10 Impact factor: 2.651